Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
123.31
+0.84 (0.68%)
Dec 3, 2024, 2:09 PM EST - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 123, with a low estimate of 101 and a high estimate of 139. The average target predicts a decrease of -0.25% from the current stock price of 123.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CAH stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 5 | 5 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $119 → $127 | Buy | Maintains | $119 → $127 | +3.00% | Nov 4, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $119 → $124 | Hold | Maintains | $119 → $124 | +0.56% | Nov 4, 2024 |
| UBS | UBS | Strong Buy Maintains $134 → $139 | Strong Buy | Maintains | $134 → $139 | +12.73% | Nov 4, 2024 |
| Mizuho | Mizuho | Hold Maintains $110 → $120 | Hold | Maintains | $110 → $120 | -2.68% | Nov 4, 2024 |
| Barclays | Barclays | Buy Maintains $117 → $133 | Buy | Maintains | $117 → $133 | +7.86% | Nov 4, 2024 |
Financial Forecast
Revenue This Year
221.49B
from 226.83B
Decreased by -2.36%
Revenue Next Year
240.04B
from 221.49B
Increased by 8.38%
EPS This Year
7.89
from 3.45
Increased by 128.60%
EPS Next Year
8.75
from 7.89
Increased by 10.96%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 233.2B | 257.4B | 282.3B | |
| Avg | 221.5B | 240.0B | 256.9B | |
| Low | 209.0B | 227.4B | 242.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.8% | 16.2% | 17.6% | |
| Avg | -2.4% | 8.4% | 7.0% | |
| Low | -7.9% | 2.7% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 8.35 | 9.44 | 10.62 | |
| Avg | 7.89 | 8.75 | 9.70 | |
| Low | 7.45 | 8.24 | 9.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 142.0% | 19.7% | 21.3% | |
| Avg | 128.6% | 11.0% | 10.9% | |
| Low | 115.9% | 4.5% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.